ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,030 filers reported holding ASTRAZENECA PLC in Q1 2023. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $728,058 | -2.2% | 10,751 | +3.3% | 0.09% | -1.1% |
| Q2 2023 | $744,757 | +6.5% | 10,406 | +3.3% | 0.10% | -1.0% |
| Q1 2023 | $699,514 | +39.7% | 10,078 | +36.4% | 0.10% | +20.0% |
| Q4 2022 | $500,771 | +24.9% | 7,386 | +1.0% | 0.08% | +9.6% |
| Q3 2022 | $401,000 | -17.7% | 7,316 | -0.7% | 0.07% | -17.0% |
| Q2 2022 | $487,000 | +13.8% | 7,366 | +14.1% | 0.09% | +17.3% |
| Q1 2022 | $428,000 | +32.5% | 6,455 | +16.3% | 0.08% | +21.0% |
| Q4 2021 | $323,000 | -23.6% | 5,550 | -21.3% | 0.06% | -36.7% |
| Q3 2021 | $423,000 | +23.7% | 7,049 | +23.6% | 0.10% | +18.1% |
| Q2 2021 | $342,000 | +52.0% | 5,704 | +26.1% | 0.08% | +27.7% |
| Q1 2021 | $225,000 | +6.1% | 4,523 | +6.6% | 0.06% | -11.0% |
| Q4 2020 | $212,000 | -0.9% | 4,243 | +8.7% | 0.07% | -16.1% |
| Q3 2020 | $214,000 | – | 3,905 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |